# Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

> **NCT00000217** · PHASE2 · COMPLETED · sponsor: **University of Kansas**

## Conditions studied

- Cocaine-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT00000217
- **Lead sponsor:** University of Kansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1990-09
- **Primary completion:** 1996-10
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000217, "Pharmacotherapy and Intensive Treatment of Drug Abuse - 1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*